Top compounds associated with response to BOC


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.01
mRNA BRD-K97651142 CTRPv2 pan-cancer AAC -0.1 0.01
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC 0.19 0.01
mRNA lapatinib gCSI pan-cancer AAC -0.14 0.01
mRNA Docetaxel CTRPv2 pan-cancer AAC -0.13 0.01
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.02
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.02
mRNA dabrafenib CTRPv2 pan-cancer AAC -0.12 0.02
mRNA BMS-270394 CTRPv2 pan-cancer AAC 0.091 0.02
mRNA MK-0752 CTRPv2 pan-cancer AAC 0.094 0.02
Download CSV